ARCT   $8.85  0.11% Market Closed After Close 8.91 0.68%

Arcturus Therapeutics Holdings Inc.
Total Cash 260.33M
totalCashPerShare 9.627
EBITDA -85.67M
Total Debt 30.88M
quickRatio 3.101
currentRatio 3.783
Total Revenue 163.87M
debtToEquity 11.942
Revenue/Share 6.112
ROA -0.13598
ROE -0.26468
grossProfits
freeCashflow -40.45M
operatingCashflow -68.73M
earningsGrowth
revenueGrowth 3.74
grossMargins -0.18428
ebitdaMargins -0.52279997
operatingMargins -0.42371
profitMargins -0.43915
enterpriseValue 266.78M
forwardPE -8.486111
floatShares 24.76M
sharesOutstanding 27.04M
sharesShort 4.43M
sharesShortPriorMonth 5.23M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.97%
Short Ratio help_outline 12.22%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 9.562
Price To Book help_outline 1.92
earningsQuarterlyGrowth
netIncomeToCommon -71.96M
trailingEps -2.69%
forwardEps -2.16%
enterpriseToEbitda -3.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.22 3Q 2024
institutionsCount 255
lastUpdated Nov. 7, 2024, 2:45 a.m.